Skip to main content
Clinical Trials/DRKS00033194
DRKS00033194
Recruiting
未知

Skeletal muscle phenotype and its association with glucometabolic status in patients with type 2 diabetes, overweight-to-obese and healthy individuals. - MuscleDiab

Deutsches Luft- und Raumfahrtzentrum, Institut für Luft- und Raumfahrtmedizin0 sites60 target enrollmentDecember 7, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
E11
Sponsor
Deutsches Luft- und Raumfahrtzentrum, Institut für Luft- und Raumfahrtmedizin
Enrollment
60
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Deutsches Luft- und Raumfahrtzentrum, Institut für Luft- und Raumfahrtmedizin

Eligibility Criteria

Inclusion Criteria

  • Individuals with T2D:
  • Female and male individuals with T2D diagnosis according to ADA criteria
  • No participation in structured exercise programs for \=6 months
  • BMI between 19 and 35 kg/m2
  • Age between 24 and 69 years
  • Signed informed consent
  • Overweight\-toobese individuals:
  • Female and male participants with
  • normal glucose tolerance
  • Sex\-, age\- and physical activity levelmatched to individuals with T2

Exclusion Criteria

  • Contra\-indications against biopsy (e.g. impaired hemostasis,
  • keloidosis, history of adverse reactions to local anesthesia or to surgical
  • procedures)
  • Contra\-indications against magnetic resonance imaging, including metal implants or other osteosynthesis material, not MRI compatible stents, clips
  • etc., pacemakers, infusion pumps, claustrophobia
  • neurological conditions
  • including strokes, brain hemorrhage, aneurysms, brain tumors,
  • neurodegenerative diseases, seizures, head trauma based on medical history
  • Cardiovascular conditions including acute coronary artery disease with coronary angina or myocardial infarction in the last 6 months,
  • heart failure (NYHA III\-IV), ventricular or atrial arrhythmias, pacemaker, recurrent syncope,

Outcomes

Primary Outcomes

Not specified

Similar Trials